Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
Currently, no vaccine exists for hepatitis C virus (HCV), a major pathogen thought to infect 170 million people globally. Many studies suggest that host T cell responses are critical for spontaneous resolution of disease, and preclinical studies have indicated a requirement for T cells in protection...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Journal article |
語言: | English |
出版: |
American Association for the Advancement of Science
2012
|